Related Experiment Video

Updated: Jun 27, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

Steatorrhoea complicating post-infectious diarrhoea in a renal transplant patient on mycophenolate mofetil therapy

Senyo Tagboto1, Farman Akhtar2

  • 1Department of Nephrology, The Royal Infirmary, University Hospital of North Staffordshire, Stoke on Trent, Staffordshire, ST4 6QG, UK. Senyo.Tagboto@uhns.nhs.uk.

Clinical and Experimental Nephrology
|December 11, 2008
PubMed

Insights

Mycophenolate mofetil (MMF) can cause reversible steatorrhoea, a fat malabsorption condition. This occurs in renal transplant patients, especially after infectious diarrhea, highlighting a potential gastrointestinal side effect.

Area of Science:

  • Gastroenterology
  • Nephrology
  • Pharmacology

Background:

  • Mycophenolate mofetil (MMF) is a key immunosuppressant for preventing renal transplant rejection.
  • Gastrointestinal (GI) adverse effects are common with MMF, including diarrhea, nausea, and abdominal discomfort.
  • Recent literature suggests MMF may induce villous atrophy, nutrient malabsorption, and colonic mucosal changes.

Observation:

  • This report details a renal transplant patient experiencing steatorrhoea.
  • The patient was undergoing combination therapy with MMF.
  • The onset of steatorrhoea followed an episode of infectious diarrhea.

Findings:

  • The case demonstrates reversible steatorrhoea in a patient treated with MMF.
  • This suggests a potential link between MMF, prior infection, and fat malabsorption.
  • MMF-induced gastrointestinal changes may manifest as steatorrhoea.

Implications:

  • Clinicians should consider MMF as a potential cause of steatorrhoea in renal transplant recipients.
  • Early recognition and management of MMF-associated malabsorption are crucial.
  • Further research is warranted to elucidate the mechanisms of MMF-induced GI toxicity.

More Related Videos

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

Related Concept Videos

Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...